ALKEMBSEAlkem Laboratories LtdMediumNeutral
Announced Mon, 18 May · 12:34 IST

Please find Attached herewith Intimation regarding Appointment of Senior Management Personnel.

Management Changes View source PDF

ALKEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.3%1-day move
₹5485.00
prior close
₹5429.50
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.1+0.0+0.1-0.3-0.8+0.5-1.3-1.5-0.2-3.0-1.9+3.1
Up moveDown movePending
AI summary

Alkem Laboratories Ltd announced the appointment of Mr. Chanakya Misra as Senior Management Personnel, effective 18th May, 2026. Misra holds an MBA in Marketing & International Business and a Bachelor of Pharmacy from IIT (BHU). He brings over 25 years of professional experience across pharmaceuticals, public health, rare diseases, and healthcare ecosystems. The appointment follows SEBI LODR Regulations disclosure requirements under Regulation 30. The term of appointment is linked to his employment duration with the company.

Likely market impact

The appointment of an experienced senior executive like Misra could be viewed positively as it strengthens Alkem's management team with healthcare and pharmaceutical expertise. However, this is a routine senior management appointment rather than a top-level leadership change, so the impact on stock price is expected to be neutral to mildly positive.